8-K: GoodRx Holdings Annual Meeting: Directors Elected, Auditors Ratified
Annual Meeting of Stockholders Results
GoodRx Holdings, Inc. reported the final voting results from its Annual Meeting of Stockholders held on June 16, 2026, confirming the election of directors, ratification of auditors, and approval of executive compensation.
Summary
- GoodRx Holdings, Inc. held its Annual Meeting of Stockholders on June 16, 2026.
- The meeting confirmed the election of three Class III directors: Wendy Barnes, Ronald E. Bruehlman, and Gregory Mondre, for terms expiring in 2029.
- KPMG LLP was ratified as the independent registered public accounting firm for the fiscal year ending December 31, 2026.
- Stockholders approved, on an advisory basis, the compensation of the company's named executive officers.
- A significant majority of voting power was represented, with approximately 99.4% of the combined voting power of Class A and Class B common stock present.
Sentiment
Score: 7
Explanation: StockSavvy.ai views this as a neutral to slightly positive filing, reflecting routine corporate governance procedures being executed smoothly with strong stockholder participation and consensus.
Positives
- High stockholder turnout, with approximately 99.4% of combined voting power represented at the Annual Meeting.
- Unanimous election of directors with overwhelming support.
- Strong ratification of KPMG LLP as the independent auditor.
- Advisory approval of executive compensation indicates general stockholder confidence in management's remuneration practices.
Future Outlook
The filing does not contain specific forward-looking statements or guidance, but the election of directors and ratification of auditors set the stage for the company's operations in the upcoming fiscal year.
Industry Context
StockSavvy.ai notes that the smooth execution of annual meetings with high participation and clear voting outcomes is a standard indicator of stable corporate governance within the healthcare technology sector.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Class III Director | N/A | Wendy Barnes | June 16, 2026 | Election by stockholders |
| Class III Director | N/A | Ronald E. Bruehlman | June 16, 2026 | Election by stockholders |
| Class III Director | N/A | Gregory Mondre | June 16, 2026 | Election by stockholders |
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Director Election | Election of three Class III directors for a term of office expiring on the date of the Annual Meeting of Stockholders to be held in 2029. | June 16, 2026 | Ensures continuity in board leadership and oversight. |
| Auditor Ratification | Ratification of the appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. | June 16, 2026 | Confirms the engagement of an independent auditor, crucial for financial reporting integrity. |
| Executive Compensation Approval | Approval, on an advisory (non-binding) basis, of the compensation of the Company's named executive officers. | June 16, 2026 | Provides an indication of shareholder sentiment regarding executive pay practices. |
Stakeholder Impact
- Shareholders: Confirmation of board composition and auditor independence reinforces confidence in company oversight and financial reporting.
- Management: Advisory approval of compensation signals shareholder support for current executive remuneration strategies.
Next Steps
- The elected Class III directors will serve until the Annual Meeting of Stockholders in 2029.
- KPMG LLP will serve as the independent registered public accounting firm for the fiscal year ending December 31, 2026.
Key Dates
| Date | Description |
|---|---|
| 2026-04-20 | Record Date for determining stockholders entitled to vote at the Annual Meeting. |
| 2026-04-29 | Date GoodRx Holdings filed its Definitive Proxy Statement. |
| 2026-06-16 | Date of the Annual Meeting of Stockholders. |
| 2026-12-31 | Fiscal year end for which KPMG LLP was appointed as auditor. |
Keywords
GoodRx Holdings, Annual Meeting, Stockholder Vote, Director Election, KPMG LLP, Executive Compensation, Corporate Governance, Form 8-K
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.